| Bioactivity | EBV BZLF1 (190-197) is an immunodominant CEF-controlling peptide derived from Epstein-Barr virus (EBV). EBV BZLF1 (190-197) is a suitable epitope for CD8+ T cells to stimulate the release of IFNg. CTL responses to EBV BZLF1 (190-197) are diverse and cross-recognize similar peptides from both host self-proteins and bacterial proteins. EBV BZLF1 (190-197) can be used to study autoimmune diseases[1]. |
| CAS | 200124-17-0 |
| Sequence | RAKFKQLL |
| Shortening | Arg-Ala-Lys-Phe-Lys-Gln-Leu-Leu |
| Formula | C47H82N14O10 |
| Molar Mass | 1003.24 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Misko I S, et al. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease[J]. Proceedings of the National Academy of Sciences, 1999, 96(5): 2279-2284. |
EBV BZLF1 (190-197)
CAS: 200124-17-0 F: C47H82N14O10 W: 1003.24
EBV BZLF1 (190-197) is an immunodominant CEF-controlling peptide derived from Epstein-Barr virus (EBV). EBV BZLF1 (190-1
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.